For: | Li L, Liu W, Chen YH, Fan CL, Dong PL, Wei FL, Li B, Chen DX, Ding HG. Antiviral drug resistance increases hepatocellular carcinoma: A prospective decompensated cirrhosis cohort study. World J Gastroenterol 2013; 19(45): 8373-8381 [PMID: 24363530 DOI: 10.3748/wjg.v19.i45.8373] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i45/8373.htm |
Number | Citing Articles |
1 |
Nishika Sahini, Jürgen Borlak. Genomics of human fatty liver disease reveal mechanistically linked lipid droplet–associated gene regulations in bland steatosis and nonalcoholic steatohepatitis. Translational Research 2016; 177: 41 doi: 10.1016/j.trsl.2016.06.003
|
2 |
Shun Ishido, Nobuharu Tamaki, Naoki Uchihara, Keito Suzuki, Yuki Tanaka, Haruka Miyamoto, Michiko Yamada, Hiroaki Matsumoto, Tsubasa Nobusawa, Taisei Keitoku, Kenta Takaura, Shohei Tanaka, Chiaki Maeyashiki, Yutaka Yasui, Yuka Takahashi, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Masayuki Kurosaki, Namiki Izumi. Switching from entecavir to tenofovir alafenamide for maintaining complete virological response in chronic hepatitis B. JGH Open 2023; 7(8): 567 doi: 10.1002/jgh3.12950
|
3 |
Peng Li, Huiguo Ding. Stratified screening of hepatocellular carcinoma in high-risk populations. Radiology of Infectious Diseases 2015; 2(2): 109 doi: 10.1016/j.jrid.2015.07.002
|
4 |
M. E. El-Houseini, A. Ismail, A. A. Abdelaal, A. H. El-Habashy, Z. F. Abdallah, M. Z. Mohamed, M. El-Hadidi, W. C. S. Cho, H. Ahmed, T. A. Al-Shafie. Role of TGF-β1 and C-Kit Mutations in the Development of Hepatocellular Carcinoma in Hepatitis C Virus-Infected Patients: in vitro Study. Biochemistry (Moscow) 2019; 84(8): 941 doi: 10.1134/S0006297919080108
|
5 |
Yuanyuan Kong, Tingting Lv, Min Li, Lianghui Zhao, Tongtong Meng, Shanshan Wu, Wei Wei, Qian Zhang, Sha Chen, Hong You, Sabela Lens, Hitoshi Yoshiji, Sven Francque, Emmanouil Tsochatzis, Shiv K. Sarin, Mattias Mandorfer, Jidong Jia. Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver disease. Hepatology International 2022; 16(5): 1052 doi: 10.1007/s12072-022-10369-w
|
6 |
Xin Zhang, Hui-Guo Ding. Key role of hepatitis B virus mutation in chronic hepatitis B development to hepatocellular carcinoma. World Journal of Hepatology 2015; 7(9): 1282-1286 doi: 10.4254/wjh.v7.i9.1282
|
7 |
Takayuki Shimizu, Taku Aoki, Shozo Mori, Yukihiro Iso, Masato Kato, Mitsuru Ishizuka, Keiichi Kubota. Tumor DNA-dependent protein kinase catalytic subunit expression is associated with hepatitis B surface antigen status and tumor progression in patients with hepatocellular carcinoma. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-33427-6
|
8 |
Ming-Wei Lai, Kung-Hao Liang, Chau-Ting Yeh. Hepatitis B Virus preS/S Truncation Mutant rtM204I/sW196* Increases Carcinogenesis through Deregulated HIF1A, MGST2, and TGFbi. International Journal of Molecular Sciences 2020; 21(17): 6366 doi: 10.3390/ijms21176366
|
9 |
Xiaoyan Wang, Yanyan Liu, Jingjing Zhao, Jinmei Zhang. Clinical efficacy of octreotide acetate combined with thrombin in the treatment of liver cirrhosis complicated with gastrointestinal hemorrhage. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7345
|